Links

Impact of robots on workers comp.What drives low income inequality in Nordic countries?Wean patients off GLP-1s?Ebola outbreak.Will Most Favored Nation backfire?

Read More

Red Light Therapy’s Regulatory Implications

For consumers and clinicians the difference between “FDA-cleared,” “FDA-registered,” and general wellness products is not always obvious. Clear communication about intended use and supporting evidence is essential for maintaining trust. The post Red Light Therapy’s Regulatory Implications appeared first on MedCity News.

Read More

Boehringer Boosts Pipeline, Adding Oral Small Molecules With Broad Immunology & Inflammation Potential

Boehringer Ingelheim receives rights to oral small molecules from Sitryx with potential applications in multiple autoimmune disorders. Depending on the progress of Boehringer’s research, Sitryx could receive more than $500 million. The post Boehringer Boosts Pipeline, Adding Oral Small Molecules With Broad Immunology & Inflammation Potential appeared first on MedCity News.

Read More